Change of Quarterly NAV valuation

RNS Number : 1802U

Port Erin Biopharma Investments Ltd

16 December 2011

 



16 December 2011

Port Erin Biopharma Investments Limited

("Port Erin" or the "Company")

Change of Quarterly NAV valuation

The Board of Port Erin has agreed with its Nominated Adviser to change the quarter day NAV valuation from 15 December 2011 and every three months thereafter to coincide with calendar quarters. It therefore proposes to release an NAV valuation and a full breakdown of investments made as at 31 December 2011 in the first half of January 2012.

Enquiries:

Port Erin Biopharma Investments
Tom Winnifrith, CIO	[phone]
Libertas Capital Corporate Finance Limited
Sandy Jamieson	[phone]
Rivington Street Corporate Finance Limited
Jon Levinson	[phone]

 

END

 

 

NAVDKADBABDDQBD